{"schema_version":"secwatch.filing_event.v1","accession":"0000318154-26-000124","form_type":"8-K","ticker":"AMGN","cik":"0000318154","company_name":"AMGEN INC","filed_at":"2026-08-04T20:03:16+00:00","discovered_at":"2026-08-04T20:04:00.992586+00:00","generated_at":"2026-08-04T20:04:07.652320+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Amgen Q2 2026 revenue up 10% to $10.1B; GAAP EPS $4.37 (+65%), non-GAAP EPS $6.29 (+4%)","bullets":["Total revenues $10.1B (+10% YoY); product sales +9% driven by volume growth.","GAAP EPS $4.37 (+65% from $2.65); non-GAAP EPS $6.29 (+4% from $6.02).","GAAP operating margin 36.8% (+6.5pp); non-GAAP operating margin 48.4% (-0.5pp).","Free cash flow $3.5B vs $1.9B in Q2 2025, helped by final repatriation tax payment timing.","Six key growth drivers +26% YoY, ~70% of product sales; 22 products double-digit growth."],"urls":{"canonical":"https://secwatch.observer/filing/0000318154-26-000124","json":"https://secwatch.observer/filing/0000318154-26-000124.json","markdown":"https://secwatch.observer/filing/0000318154-26-000124.md","text":"https://secwatch.observer/filing/0000318154-26-000124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000124/0000318154-26-000124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/318154/000031815426000124/amgn-20260804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T20:04:07.652320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}